Figure S4 from Targeting TREX1 Induces Innate Immune Response in Drug-Resistant Small-Cell Lung Cancer Article Swipe

View

Takahiko Murayama , Navin R. Mahadevan , Catherine B. Meador , Elena V. Ivanova , Yuqiao Pan , Erik H. Knelson , Tetsuo Tani , Jun Nakayama , Xueying Ma , Tran C. Thai , Yin P. Hung , William Kim , Hideo Watanabe , Kathy Q. Cai , Aaron N. Hata , Cloud P. Paweletz , David A. Barbie , Israel Cañadas ·

YOU? · · 2025 · Open Access · · DOI: https://doi.org/10.1158/2767-9764.28728107

Figure S4 shows TREX1 depletion increases sensitivity of resistant SCLC cells to chemotherapy

Related Topics

Concepts

Innate immune system Drug Lung cancer Immune system Cancer research Medicine Immunology Biology Pharmacology Oncology

Metadata

Type: preprint
Language: en
Landing Page: https://doi.org/10.1158/2767-9764.28728107
OA Status: gold
Related Works: 10
OpenAlex ID: https://openalex.org/W4409127371

All OpenAlex metadata

Raw OpenAlex JSON

OpenAlex ID: https://openalex.org/W4409127371

Canonical identifier for this work in OpenAlex
DOI: https://doi.org/10.1158/2767-9764.28728107

Digital Object Identifier
Title: Figure S4 from Targeting TREX1 Induces Innate Immune Response in Drug-Resistant Small-Cell Lung Cancer

Work title
Type: preprint

OpenAlex work type
Language: en

Primary language
Publication year: 2025

Year of publication
Publication date: 2025-04-03

Full publication date if available
Authors: Takahiko Murayama, Navin R. Mahadevan, Catherine B. Meador, Elena V. Ivanova, Yuqiao Pan, Erik H. Knelson, Tetsuo Tani, Jun Nakayama, Xueying Ma, Tran C. Thai, Yin P. Hung, William Kim, Hideo Watanabe, Kathy Q. Cai, Aaron N. Hata, Cloud P. Paweletz, David A. Barbie, Israel Cañadas

List of authors in order
Landing page: https://doi.org/10.1158/2767-9764.28728107

Publisher landing page
Open access: Yes

Whether a free full text is available
OA status: gold

Open access status per OpenAlex
OA URL: https://doi.org/10.1158/2767-9764.28728107

Direct OA link when available
Concepts: Innate immune system, Drug, Lung cancer, Immune system, Cancer research, Medicine, Immunology, Biology, Pharmacology, Oncology

Top concepts (fields/topics) attached by OpenAlex
Cited by: 0

Total citation count in OpenAlex
Related works (count): 10

Other works algorithmically related by OpenAlex

Full payload

id	https://openalex.org/W4409127371
doi	https://doi.org/10.1158/2767-9764.28728107
ids.doi	https://doi.org/10.1158/2767-9764.28728107
ids.openalex	https://openalex.org/W4409127371
fwci
type	preprint
title	Figure S4 from Targeting TREX1 Induces Innate Immune Response in Drug-Resistant Small-Cell Lung Cancer
biblio.issue
biblio.volume
biblio.last_page
biblio.first_page
topics[0].id	https://openalex.org/T11668
topics[0].field.id	https://openalex.org/fields/24
topics[0].field.display_name	Immunology and Microbiology
topics[0].score	0.9926999807357788
topics[0].domain.id	https://openalex.org/domains/1
topics[0].domain.display_name	Life Sciences
topics[0].subfield.id	https://openalex.org/subfields/2403
topics[0].subfield.display_name	Immunology
topics[0].display_name	interferon and immune responses
topics[1].id	https://openalex.org/T11503
topics[1].field.id	https://openalex.org/fields/27
topics[1].field.display_name	Medicine
topics[1].score	0.9685999751091003
topics[1].domain.id	https://openalex.org/domains/4
topics[1].domain.display_name	Health Sciences
topics[1].subfield.id	https://openalex.org/subfields/2730
topics[1].subfield.display_name	Oncology
topics[1].display_name	Cytokine Signaling Pathways and Interactions
topics[2].id	https://openalex.org/T12334
topics[2].field.id	https://openalex.org/fields/27
topics[2].field.display_name	Medicine
topics[2].score	0.9678999781608582
topics[2].domain.id	https://openalex.org/domains/4
topics[2].domain.display_name	Health Sciences
topics[2].subfield.id	https://openalex.org/subfields/2730
topics[2].subfield.display_name	Oncology
topics[2].display_name	Lung Cancer Research Studies
is_xpac	False
apc_list
apc_paid
concepts[0].id	https://openalex.org/C136449434
concepts[0].level	3
concepts[0].score	0.7815200686454773
concepts[0].wikidata	https://www.wikidata.org/wiki/Q428253
concepts[0].display_name	Innate immune system
concepts[1].id	https://openalex.org/C2780035454
concepts[1].level	2
concepts[1].score	0.6487836837768555
concepts[1].wikidata	https://www.wikidata.org/wiki/Q8386
concepts[1].display_name	Drug
concepts[2].id	https://openalex.org/C2776256026
concepts[2].level	2
concepts[2].score	0.6181122660636902
concepts[2].wikidata	https://www.wikidata.org/wiki/Q47912
concepts[2].display_name	Lung cancer
concepts[3].id	https://openalex.org/C8891405
concepts[3].level	2
concepts[3].score	0.5801804065704346
concepts[3].wikidata	https://www.wikidata.org/wiki/Q1059
concepts[3].display_name	Immune system
concepts[4].id	https://openalex.org/C502942594
concepts[4].level	1
concepts[4].score	0.45813870429992676
concepts[4].wikidata	https://www.wikidata.org/wiki/Q3421914
concepts[4].display_name	Cancer research
concepts[5].id	https://openalex.org/C71924100
concepts[5].level	0
concepts[5].score	0.37435728311538696
concepts[5].wikidata	https://www.wikidata.org/wiki/Q11190
concepts[5].display_name	Medicine
concepts[6].id	https://openalex.org/C203014093
concepts[6].level	1
concepts[6].score	0.3714115619659424
concepts[6].wikidata	https://www.wikidata.org/wiki/Q101929
concepts[6].display_name	Immunology
concepts[7].id	https://openalex.org/C86803240
concepts[7].level	0
concepts[7].score	0.3588264286518097
concepts[7].wikidata	https://www.wikidata.org/wiki/Q420
concepts[7].display_name	Biology
concepts[8].id	https://openalex.org/C98274493
concepts[8].level	1
concepts[8].score	0.26657742261886597
concepts[8].wikidata	https://www.wikidata.org/wiki/Q128406
concepts[8].display_name	Pharmacology
concepts[9].id	https://openalex.org/C143998085
concepts[9].level	1
concepts[9].score	0.14185112714767456
concepts[9].wikidata	https://www.wikidata.org/wiki/Q162555
concepts[9].display_name	Oncology
keywords[0].id	https://openalex.org/keywords/innate-immune-system
keywords[0].score	0.7815200686454773
keywords[0].display_name	Innate immune system
keywords[1].id	https://openalex.org/keywords/drug
keywords[1].score	0.6487836837768555
keywords[1].display_name	Drug
keywords[2].id	https://openalex.org/keywords/lung-cancer
keywords[2].score	0.6181122660636902
keywords[2].display_name	Lung cancer
keywords[3].id	https://openalex.org/keywords/immune-system
keywords[3].score	0.5801804065704346
keywords[3].display_name	Immune system
keywords[4].id	https://openalex.org/keywords/cancer-research
keywords[4].score	0.45813870429992676
keywords[4].display_name	Cancer research
keywords[5].id	https://openalex.org/keywords/medicine
keywords[5].score	0.37435728311538696
keywords[5].display_name	Medicine
keywords[6].id	https://openalex.org/keywords/immunology
keywords[6].score	0.3714115619659424
keywords[6].display_name	Immunology
keywords[7].id	https://openalex.org/keywords/biology
keywords[7].score	0.3588264286518097
keywords[7].display_name	Biology
keywords[8].id	https://openalex.org/keywords/pharmacology
keywords[8].score	0.26657742261886597
keywords[8].display_name	Pharmacology
keywords[9].id	https://openalex.org/keywords/oncology
keywords[9].score	0.14185112714767456
keywords[9].display_name	Oncology
language	en
locations[0].id	doi:10.1158/2767-9764.28728107
locations[0].is_oa	True
locations[0].source
locations[0].license	cc-by
locations[0].pdf_url
locations[0].version	acceptedVersion
locations[0].raw_type	posted-content
locations[0].license_id	https://openalex.org/licenses/cc-by
locations[0].is_accepted	True
locations[0].is_published	False
locations[0].raw_source_name
locations[0].landing_page_url	https://doi.org/10.1158/2767-9764.28728107
indexed_in	crossref
authorships[0].author.id	https://openalex.org/A5033694632
authorships[0].author.orcid	https://orcid.org/0000-0003-0764-8646
authorships[0].author.display_name	Takahiko Murayama
authorships[0].author_position	first
authorships[0].raw_author_name	Takahiko Murayama
authorships[0].is_corresponding	False
authorships[1].author.id	https://openalex.org/A5087814181
authorships[1].author.orcid	https://orcid.org/0000-0002-6805-8861
authorships[1].author.display_name	Navin R. Mahadevan
authorships[1].author_position	middle
authorships[1].raw_author_name	Navin R. Mahadevan
authorships[1].is_corresponding	False
authorships[2].author.id	https://openalex.org/A5025951912
authorships[2].author.orcid	https://orcid.org/0000-0001-5006-3569
authorships[2].author.display_name	Catherine B. Meador
authorships[2].author_position	middle
authorships[2].raw_author_name	Catherine B. Meador
authorships[2].is_corresponding	False
authorships[3].author.id	https://openalex.org/A5072438750
authorships[3].author.orcid	https://orcid.org/0000-0002-5069-4974
authorships[3].author.display_name	Elena V. Ivanova
authorships[3].author_position	middle
authorships[3].raw_author_name	Elena V. Ivanova
authorships[3].is_corresponding	False
authorships[4].author.id	https://openalex.org/A5106678948
authorships[4].author.orcid
authorships[4].author.display_name	Yuqiao Pan
authorships[4].author_position	middle
authorships[4].raw_author_name	Yuqiao Pan
authorships[4].is_corresponding	False
authorships[5].author.id	https://openalex.org/A5005440027
authorships[5].author.orcid	https://orcid.org/0000-0003-4087-2017
authorships[5].author.display_name	Erik H. Knelson
authorships[5].author_position	middle
authorships[5].raw_author_name	Erik H. Knelson
authorships[5].is_corresponding	False
authorships[6].author.id	https://openalex.org/A5029630247
authorships[6].author.orcid	https://orcid.org/0000-0001-5719-2697
authorships[6].author.display_name	Tetsuo Tani
authorships[6].author_position	middle
authorships[6].raw_author_name	Tetsuo Tani
authorships[6].is_corresponding	False
authorships[7].author.id	https://openalex.org/A5058773471
authorships[7].author.orcid	https://orcid.org/0000-0001-8844-4295
authorships[7].author.display_name	Jun Nakayama
authorships[7].author_position	middle
authorships[7].raw_author_name	Jun Nakayama
authorships[7].is_corresponding	False
authorships[8].author.id	https://openalex.org/A5038629981
authorships[8].author.orcid	https://orcid.org/0009-0006-5161-1073
authorships[8].author.display_name	Xueying Ma
authorships[8].author_position	middle
authorships[8].raw_author_name	Xueying Ma
authorships[8].is_corresponding	False
authorships[9].author.id	https://openalex.org/A5058643322
authorships[9].author.orcid	https://orcid.org/0000-0003-4799-0876
authorships[9].author.display_name	Tran C. Thai
authorships[9].author_position	middle
authorships[9].raw_author_name	Tran C. Thai
authorships[9].is_corresponding	False
authorships[10].author.id	https://openalex.org/A5039324896
authorships[10].author.orcid	https://orcid.org/0000-0002-8568-1591
authorships[10].author.display_name	Yin P. Hung
authorships[10].author_position	middle
authorships[10].raw_author_name	Yin P. Hung
authorships[10].is_corresponding	False
authorships[11].author.id	https://openalex.org/A5077158875
authorships[11].author.orcid	https://orcid.org/0000-0002-3021-7193
authorships[11].author.display_name	William Kim
authorships[11].author_position	middle
authorships[11].raw_author_name	William Kim
authorships[11].is_corresponding	False
authorships[12].author.id	https://openalex.org/A5024413045
authorships[12].author.orcid	https://orcid.org/0000-0002-6017-6361
authorships[12].author.display_name	Hideo Watanabe
authorships[12].author_position	middle
authorships[12].raw_author_name	Hideo Watanabe
authorships[12].is_corresponding	False
authorships[13].author.id	https://openalex.org/A5079001775
authorships[13].author.orcid	https://orcid.org/0000-0002-6034-3377
authorships[13].author.display_name	Kathy Q. Cai
authorships[13].author_position	middle
authorships[13].raw_author_name	Kathy Q. Cai
authorships[13].is_corresponding	False
authorships[14].author.id	https://openalex.org/A5087906702
authorships[14].author.orcid	https://orcid.org/0000-0002-6127-318X
authorships[14].author.display_name	Aaron N. Hata
authorships[14].author_position	middle
authorships[14].raw_author_name	Aaron N. Hata
authorships[14].is_corresponding	False
authorships[15].author.id	https://openalex.org/A5056573353
authorships[15].author.orcid	https://orcid.org/0000-0002-2287-5663
authorships[15].author.display_name	Cloud P. Paweletz
authorships[15].author_position	middle
authorships[15].raw_author_name	Cloud P. Paweletz
authorships[15].is_corresponding	False
authorships[16].author.id	https://openalex.org/A5060353514
authorships[16].author.orcid	https://orcid.org/0000-0002-5422-4275
authorships[16].author.display_name	David A. Barbie
authorships[16].author_position	middle
authorships[16].raw_author_name	David A. Barbie
authorships[16].is_corresponding	False
authorships[17].author.id	https://openalex.org/A5090611170
authorships[17].author.orcid	https://orcid.org/0000-0001-6474-711X
authorships[17].author.display_name	Israel Cañadas
authorships[17].author_position	last
authorships[17].raw_author_name	Israel Cañadas
authorships[17].is_corresponding	False
has_content.pdf	False
has_content.grobid_xml	False
is_paratext	False
open_access.is_oa	True
open_access.oa_url	https://doi.org/10.1158/2767-9764.28728107
open_access.oa_status	gold
open_access.any_repository_has_fulltext	False
created_date	2025-10-10T00:00:00
display_name	Figure S4 from Targeting TREX1 Induces Innate Immune Response in Drug-Resistant Small-Cell Lung Cancer
has_fulltext	False
is_retracted	False
updated_date	2025-11-06T03:46:38.306776
primary_topic.id	https://openalex.org/T11668
primary_topic.field.id	https://openalex.org/fields/24
primary_topic.field.display_name	Immunology and Microbiology
primary_topic.score	0.9926999807357788
primary_topic.domain.id	https://openalex.org/domains/1
primary_topic.domain.display_name	Life Sciences
primary_topic.subfield.id	https://openalex.org/subfields/2403
primary_topic.subfield.display_name	Immunology
primary_topic.display_name	interferon and immune responses
related_works	https://openalex.org/W2066136773, https://openalex.org/W1495541589, https://openalex.org/W2565121077, https://openalex.org/W2130166758, https://openalex.org/W2316042956, https://openalex.org/W1987802636, https://openalex.org/W2158827209, https://openalex.org/W4285733331, https://openalex.org/W3195238582, https://openalex.org/W2190283986
cited_by_count	0
locations_count	1
best_oa_location.id	doi:10.1158/2767-9764.28728107
best_oa_location.is_oa	True
best_oa_location.source
best_oa_location.license	cc-by
best_oa_location.pdf_url
best_oa_location.version	acceptedVersion
best_oa_location.raw_type	posted-content
best_oa_location.license_id	https://openalex.org/licenses/cc-by
best_oa_location.is_accepted	True
best_oa_location.is_published	False
best_oa_location.raw_source_name
best_oa_location.landing_page_url	https://doi.org/10.1158/2767-9764.28728107
primary_location.id	doi:10.1158/2767-9764.28728107
primary_location.is_oa	True
primary_location.source
primary_location.license	cc-by
primary_location.pdf_url
primary_location.version	acceptedVersion
primary_location.raw_type	posted-content
primary_location.license_id	https://openalex.org/licenses/cc-by
primary_location.is_accepted	True
primary_location.is_published	False
primary_location.raw_source_name
primary_location.landing_page_url	https://doi.org/10.1158/2767-9764.28728107
publication_date	2025-04-03
publication_year	2025
referenced_works_count	0
abstract_inverted_index.S4	1
abstract_inverted_index.of	7
abstract_inverted_index.to	11
abstract_inverted_index.SCLC	9
abstract_inverted_index.TREX1	3
abstract_inverted_index.cells	10
abstract_inverted_index.shows	2
abstract_inverted_index.depletion	4
abstract_inverted_index.increases	5
abstract_inverted_index.resistant	8
abstract_inverted_index.sensitivity	6
abstract_inverted_index.<p>Figure	0
abstract_inverted_index.chemotherapy</p>	12
cited_by_percentile_year
countries_distinct_count	0
institutions_distinct_count	18
citation_normalized_percentile.value	0.12547568
citation_normalized_percentile.is_in_top_1_percent	False
citation_normalized_percentile.is_in_top_10_percent	False